Trending...
- California: Three years after the end of Roe, Governor Newsom, First Partner sound the alarm on Trump's "Big, Beautiful" plan to defund Planned Parenthood - 114
- Ascent Solar Technologies Enters Collaborative Agreement Notice with NASA to Advance Development of Thin-Film PV Power Beaming Capabilities: ASTI
- California awards over $15 million to apprenticeship programs connecting youth to high-paying jobs
SAN DIEGO - Californer -- TAK1-TAB1 Fusion Human Recombinant
TAK1-TAB1 Fusion Human Recombinant is a high quality protein complex that is artificially created by combining the TAK1 (Transforming growth factor beta-activated kinase 1) and TAB1 (TAK1-binding protein 1) proteins. This fusion protein is commonly used in research settings to study the signaling pathways involved in various cellular processes, such as inflammation, immune response, and cell growth. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
TAK1-TAB1 Fusion Human Recombinant
Catalog number: B2016845
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 10 µg
Molecular Weight or Concentration: 69 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
More on The Californer
Keywords: TAK1: MAP3K7, TGF1a, TGFβ-activated Kinase 1, Mitogen-activated Protein Kinase Kinase Kinase 7, Transforming Growth Factor-β-activated Kinase 1, TGF-β-activated Kinase 1, TAB1: MAP3K7IP1, TAK1-binding Protein 1, TGF-β-activated Kinase 1 and MAP3K7-binding Protein 1, Mitogen-activated Protein Kinase Kinase Kinase 7-interacting Protein 1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Sakurai H, Nishi A, Sato N, Mizukami J, Miyoshi H, Sugita T. TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways Biochem Biophys Res Commun. 2002 Oct 11;297(5):1277-81.
2: Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction Science. 1996 May 24;272(5265):1179-82.
https://moleculardepot.com/product/tak1-tab1-fusion-human-recombinant/
TAK1-TAB1 Fusion Human Recombinant is a high quality protein complex that is artificially created by combining the TAK1 (Transforming growth factor beta-activated kinase 1) and TAB1 (TAK1-binding protein 1) proteins. This fusion protein is commonly used in research settings to study the signaling pathways involved in various cellular processes, such as inflammation, immune response, and cell growth. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
TAK1-TAB1 Fusion Human Recombinant
Catalog number: B2016845
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 10 µg
Molecular Weight or Concentration: 69 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
More on The Californer
- California: Governor Newsom proclaims Immigrant Heritage Month 2025
- California: Department of Defense agrees: it's time for Trump's militarization of Los Angeles to end
- Long Beach: City Launches Internet Service Enrollment Line
- Von Rock Law Founder Deidre Von Rock Named Super Lawyer for 2025
- California: Governor Newsom extends emergency short-term housing protections in Los Angeles
Keywords: TAK1: MAP3K7, TGF1a, TGFβ-activated Kinase 1, Mitogen-activated Protein Kinase Kinase Kinase 7, Transforming Growth Factor-β-activated Kinase 1, TGF-β-activated Kinase 1, TAB1: MAP3K7IP1, TAK1-binding Protein 1, TGF-β-activated Kinase 1 and MAP3K7-binding Protein 1, Mitogen-activated Protein Kinase Kinase Kinase 7-interacting Protein 1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Sakurai H, Nishi A, Sato N, Mizukami J, Miyoshi H, Sugita T. TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways Biochem Biophys Res Commun. 2002 Oct 11;297(5):1277-81.
2: Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction Science. 1996 May 24;272(5265):1179-82.
https://moleculardepot.com/product/tak1-tab1-fusion-human-recombinant/
Source: Molecular Depot
0 Comments
Latest on The Californer
- Cymbiotika Celebrates 2025 Great Place To Work Certification™
- Long Beach: LA28 Announces Finalized Sailing Venue Plan for 2028 Olympic Games
- Individual Software Announces New Versions of its Four Typing Programs in 2025
- Britt Michaelian Brings Transformative Art & Wellness to The Ecology Center's Peace Dome
- California: Governor Newsom urges safety this Fourth of July after 600,000 pounds of illegal explosives seized
- AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- Mental and Emotional Self-Management, Practical Tools for Trauma-Informed Stress Management
- CGI+ Sells Multifamily Development Site in Los Angeles' South Bay to JPI for $40 Million
- MicroStrategy Incorporated (MSTR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Alten Construction awarded Encinal Junior and Senior High School project
- $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
- Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
- Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts
- Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
- Psychologist-Turned-Hermeticist Releases Modern Guide to the Seven Hermetic Principles
- Winners Announced for Asia Pacific Business Awards 2024-2025
- Hamvay-Lang and Lampone.hu Join Forces with AIMarketingugynokseg.hu to Elevate Hungarian Lifestyle Brands on the Global Stage